Sign in

You're signed outSign in or to get full access.

Janet O. Estep

Director at ALERUS FINANCIALALERUS FINANCIAL
Board

About Janet O. Estep

Independent director at Alerus Financial Corporation since 2021; age 68. Former CEO and President of Nacha (the U.S. ACH governing body) from 2008–2019; previously EVP of U.S. Bank’s Transaction Services Division, leadership roles at Pace Analytical, and sales/product roles at IBM. B.A. in Economics and Psychology from St. Olaf College. She brings 35+ years in payments, digital technology, product development, risk management, and regulatory oversight; she is independent under Nasdaq rules.

Past Roles

OrganizationRoleTenureCommittees/Impact
Nacha (U.S. ACH network)Chief Executive Officer & President2008–2019Led U.S. ACH governance; deep payments and regulatory expertise.
U.S. BankEVP, Transaction Services DivisionLarge-bank transaction services leadership.
Pace AnalyticalGeneral Manager; led sales/marketingOperational and commercial leadership.
IBMSales and product roles (HW/SW)Technology and product development experience.

External Roles

CompanyRoleCommitteesNotes
ACI WorldwideDirectorNominating & Governance; Audit/RiskGlobal payments software; relevant to ALRS payments ecosystem.

Board Governance

  • Independence: Independent director (all directors except the CEO were independent in 2025).
  • Committee leadership and memberships (ALRS):
    • Chair, Nominating & Corporate Governance Committee (2024–2025).
    • Member, Risk Committee (2024–2025).
  • Attendance: Met at least the 75% threshold for 2024 (all directors except Uribe and Bolton achieved ≥75% in 2024); all directors achieved ≥75% in 2023.
  • Executive sessions and board structure: Independent Executive Chairman leads executive sessions; chair/CEO roles separated.

Committee Assignments (current and prior)

Committee20242025
Nominating & Corporate GovernanceChair Chair
RiskMember Member

Fixed Compensation

  • Structure evolution:
    • 2023: $35,000 cash retainer; $35,000 stock grant (fully vested at grant); $1,000 per quarterly committee meeting; chair fees ($6,000 for Nominating & Corporate Governance).
    • 2024: $40,000 cash retainer; $50,000 restricted stock (vests at earlier of first anniversary or next annual meeting); chair fee for Nominating & Corporate Governance at $7,000 (raised to $8,000 prospectively after the 2024 annual meeting); meeting fees retained for 1H24 and eliminated thereafter.
Metric20232024
Fees earned or paid in cash (actual)$53,000 $53,000
Stock awards (grant-date fair value, actual)$35,000 $50,003
Total$88,000 $103,003
Notes (policy reference)$35k cash + $35k stock; chair $6k; meeting fees apply $40k cash + $50k RSU; chair $7k (raised to $8k post-ASM); meeting fees phased out

Performance Compensation

  • Non-employee director equity is time-based restricted stock; no performance-based metrics disclosed for director pay.
Performance Metrics Tied to Director Compensation20232024
Performance-based metrics applicable to directorsNone disclosed None disclosed

Other Directorships & Interlocks

External Public CompanyRoleCommitteesPotential Interlock/Conflict
ACI WorldwideDirectorNominating & Governance; Audit/RiskNo related-party transactions disclosed with ALRS.

Expertise & Qualifications

  • Payments and digital technology leadership: Former CEO of Nacha (2008–2019) with oversight of ACH network governance; relevant to bank payments strategy and risk.
  • Large-bank operating experience: EVP at U.S. Bank (Transaction Services), bringing operational, product, and risk insights.
  • Technology and product development grounding (IBM), plus P&L/operations at Pace Analytical.
  • Governance: Chairs ALRS Nominating & Corporate Governance; sits on ALRS Risk Committee and ACI Worldwide’s governance and audit/risk committees.

Equity Ownership

  • Stock ownership guidelines: Directors must hold 5x the annual stock retainer; as of Feb 26, 2025, all directors were compliant or within the five-year window.
  • Anti-hedging policy prohibits hedging; pledging not disclosed for Estep (others disclosed separately).
Ownership MetricAs of Mar 12, 2024As of Mar 12, 2025
Beneficially owned shares8,156 10,715
% of shares outstanding<1% <1%
Notable footnotesIncludes unvested restricted stock in count (voting) Includes 2,559 restricted shares; excludes RSUs not entitled to vote

Signals on Conflicts, Related Parties, and Compliance

  • Related-party transactions: None disclosed involving Estep; ordinary-course banking relationships reviewed under policy.
  • Section 16 compliance: 2024 proxy notes Estep had one transaction from 2022 reported late via Form 5 in 2023 (administrative timeliness issue).
  • Pledging/hedging: No Estep pledging disclosed; company prohibits hedging.
YearLate Section 16 Reporting Noted for EstepNotes
2023 (reported in 2024 proxy)Yes (1 Form 5 for a 2022 transaction) Administrative timeliness; no further issues disclosed.
2024 (reported in 2025 proxy)Not cited 2025 proxy lists late filings for other insiders, not Estep.

Governance Assessment

  • Positives

    • Independent director with deep payments/technology background; chairs Nominating & Governance and serves on Risk—aligns well with bank strategy and oversight needs.
    • Attendance met board expectations (≥75% in 2024; all directors ≥75% in 2023).
    • Ownership alignment via stock grants and compliance with director ownership guidelines (5x stock retainer).
    • Director pay structure balances cash and equity; 2024 enhancements increased equity retainer, modest chair fee increases, and phased out meeting fees—more aligned with best practices.
  • Watch items / potential red flags

    • Minor Section 16 timeliness issue in 2023 (late Form 5 for a 2022 transaction). While not material, it’s a governance hygiene item to monitor for recurrence.
    • ACI Worldwide directorship: no related-party exposures disclosed, but continue monitoring for business overlaps in payments partnerships or vendor relationships.
  • Overall view: Strong governance contributor with relevant payments and risk expertise; chairing governance and sitting on risk committees suggests meaningful influence on board effectiveness. Compensation and ownership alignment appear appropriate; no material conflicts identified.